157341-35-0

Basic information

• Product Name: 1-Cyanomethylhomopiperazine
• Synonyms: 1-Cyanomethylhomopiperazine
• CAS NO: 157341-35-0
• Molecular Formula: C7H13N3
• Molecular Weight: 139.19822
• Mol File: 157341-35-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 251°C at 760 mmHg
• Flash Point: 105.6°C
• Appearance: /
• Density: 0.978g/cm³
• Vapor Pressure: 0.021mmHg at 25°C
• Refractive Index: 1.463
• PKA: 10.33±0.20(Predicted)
• CAS DataBase Reference: 1-Cyanomethylhomopiperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Cyanomethylhomopiperazine(157341-35-0)
• EPA Substance Registry System: 1-Cyanomethylhomopiperazine(157341-35-0)

Safety Data

• Hazardous Substances Data: 157341-35-0(Hazardous Substances Data)

Usage

Derivative of homopiperazine

A modification of the homopiperazine structure, which is a six-membered saturated ring containing two nitrogen atoms.

Cyanomethyl group attachment

The cyanomethyl group is attached to one of the nitrogen atoms in the homopiperazine ring, giving the compound its unique properties.

Pharmaceutical synthesis

1-Cyanomethylhomopiperazine is used in the synthesis of pharmaceuticals, particularly in the production of drugs targeting the central nervous system.

Potential use in organic synthesis

The compound has been studied for its possible use as a building block in organic synthesis, indicating its versatility in chemical reactions.

Physical appearance

1-Cyanomethylhomopiperazine is a colorless to pale yellow liquid at room temperature, describing its visual characteristics.

Stability

The compound is considered stable under normal conditions, suggesting that it does not readily react or break down in typical environments.

InChI:InChI=1/C7H13N3/c8-2-6-10-5-1-3-9-4-7-10/h9H,1,3-7H2

Upstream product

• 505-66-8 1,4-Diazacycloheptane 
• 90230-58-3 chloroacetonitrite 

Relevant articles and documents

CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE UNCHARGED BISOXIME ANTIDOTES FOR ORGANOPHOSPHATE POISONING AND METHODS FOR MAKING AND USING THEM

In alternative embodiments, provided are uncharged bis-oxime antidotes that cross the blood-brain barrier (BBB) to catalyze the hydrolysis of organophosphate (OP)-inhibited human acetylcholinesterase (hAChE) in the central nerve system (CNS). In alternative embodiments, provided are pumps, devices, subcutaneous infusion devices, continuous subcutaneous infusion devices, infusion pens, needles, reservoirs, ampoules, a vial, a syringe, a cartridge, a disposable pen or jet injector, a prefilled pen or a syringe or a cartridge, a cartridge or a disposable pen or jet injector, a two chambered or multi-chambered pump, a syringe, a cartridge or a pen or a jet injector, comprising a compound as provided herein.

SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS

New substituted azetidinones of the general Formula (I) which have been found to be potent elastase inhibitors and thereby useful anti-inflammatory and antidegenerative agents are described. STR1 wherein R 4 is (a) STR2 or (b) STR3 where R x is carboxy C 1-6 alkyl, benzyloxycarbonylC 1-3 alkyl, or t-butoxycarbonylC 1-3 alkyl,whereinQ is a covalent bond or STR4 wherein R 5 and R 6 are each individually C 1-3 alkyl or hydrogen,Y is STR5 or a covalent bond.